<- Go Home

Oxford Immunotec Global Limited

As of March 8, 2021, operates as a subsidiary of PerkinElmer (UK) Holdings Limited.

Market Cap

$562.5M

Volume

177.3K

Cash and Equivalents

$160.6M

EBITDA

-$16.1M

Tax Rate Collected

N/A

Tax Rate Ratio

N/A

Gross Profit

$43.0M

Profit Margin

75.08%

52 Week High

$23.11

52 Week Low

$8.37

Dividend

N/A

Price / Book Value

2.98

Price / Earnings

-34.41

Price / Tangible Book Value

3.03

Enterprise Value

N/A

Enterprise Value / EBITDA

N/A

Operating Income

-$17.9M

Return on Equity

8.19%

Return on Assets

-4.99

Cash and Short Term Investments

$160.6M

Debt

$8.9M

Equity

$191.3M

Revenue

$57.3M

Unlevered FCF

-$7.2M

Sector

Health Care Equipment and Supplies

Category

N/A

Company Stock Pitches